Eluciderm Inc.

San Diego, CA · Founded 2018 · CIK 0001886373 · Biotech · Private

Regenerative medicine therapeutics for wound healing and scar minimization

eluciderm.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$3.8M
3 Form D · May 2022
53 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raised· 1 of 2 same dayForm D · SEC$4,286
Private capital raised· 2 of 2 same dayForm D · SEC$1,759,214
Private capital raisedForm D · SEC$2,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
23703D HEALTH SOLUTIONS, INC.——
2371Helicore, LLC—$2.0M
2372IMMUNE-ONC THERAPEUTICS, INC.—$7.0M
2373Eluciderm Inc.—$3.8M
2374BIO-PATH HOLDINGS, INC.—$18M
2375Indapta Therapeutic——
2376BIOINVENU CORPORATION——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • John DelgadoDirector · Executive Officer
  • Daniel HolsworthDirector · Executive Officer
  • Joseph MarinoDirector · Executive Officer
  • David MichalekExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.